Facet-Joint Injection Market Forecast To Reach $4.1 Billion By 2030: Key Trends Explained
Featuring market attractiveness scoring, total addressable market sizing, company benchmarking matrices, interactive Excel dashboards, deeper supply chain intelligence, emerging startup tracking, and granular product-level insights, The Business Research Company’s 2026 market reports are built to deliver research that is both more actionable and more strategically valuable.
Facet-Joint Injection Market Size Outlook: How Quickly Will Revenue Expand Through 2030?
The facet-joint injection market has seen robust expansion in recent years. It is projected to increase from $2.97 billion in 2025 to $3.18 billion in 2026, maintaining a compound annual growth rate (CAGR) of 6.9%. The market’s past growth is attributable to spinal degeneration prevalence, arthritis incidence, pain management awareness, corticosteroid use, and outpatient procedure growth.
The facet-joint injection market size is expected to experience robust growth over the next few years. It is forecast to reach $4.1 billion in 2030, demonstrating a compound annual growth rate (CAGR) of 6.6%. This projected growth can be attributed to factors such as an aging population, a preference for minimally invasive treatments, the prevalence of chronic pain, the expansion of ambulatory care, and the use of imaging-guided procedures. Significant trends expected during the forecast period include a heightened demand for minimally invasive pain procedures, increased application in chronic back pain management, the proliferation of outpatient pain clinics, the adoption of image-guided injection techniques, and the growth of ambulatory surgical centers.
Get A Free Sample Report With In-Depth Market Insights:
Facet-Joint Injection Market Growth Factors: What’s Supporting Expansion?
The increasing incidence of spinal conditions and persistent back pain is anticipated to fuel the expansion of the facet-joint injection market moving forward. Spinal diseases and chronic back pain encompass long-term ailments affecting the spine, such as disc degeneration, arthritis, or nerve compression, which result in ongoing discomfort, limited mobility, and a reduced quality of life. The growing prevalence of these conditions is attributed to sedentary lifestyles and poor posture, prompting individuals to seek effective, low-disruption treatments to alleviate persistent discomfort and restore functional movement. Facet-joint injections address spinal diseases and chronic back pain by diminishing pain and inflammation in the spine, offering relief to individuals suffering from the increasing issue of spinal diseases and chronic back pain. For instance, in May 2023, Spinal Cord Inc., a US-based non-profit resource center, reported that in 2023, approximately 18,000 new spinal cord injury (SCI) cases are reported annually in the United States, with an estimated 302,000 individuals currently living with spinal cord injuries nationwide. Consequently, the rising occurrence of spinal diseases and chronic back pain is driving the growth of the facet-joint injection market. The expanding demand for minimally invasive procedures is expected to propel the growth of the facet-joint injection market in the coming years. Minimally invasive procedures are medical interventions performed through small incisions or without requiring extensive surgical cuts. The increasing adoption of minimally invasive procedures is due to a growing patient preference for quicker recovery times and reduced post-operative pain. Facet-joint injections enhance minimally invasive procedures by providing targeted pain relief and diagnostic accuracy without the necessity for major surgical intervention. For example, in 2023, the American Society of Plastic Surgeons, a US-based specialty organization, indicated that the total number of minimally invasive cosmetic procedures rose from 23.7 million in 2022 to 25.4 million in 2023. Therefore, the growing demand for minimally invasive procedures is driving the growth of the facet-joint injection market.
Facet-Joint Injection Market Segment Analysis And Revenue Potential
The facet-joint injection market covered in this report is segmented –
1) By Product Type: Corticosteroids, Local Anesthetics, Hyaluronic Acid, Other Product Types
2) By Application: Cervical Facet Joints, Thoracic Facet Joints, Lumbar Facet Joints
3) By End-User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics, Other End-Users
Subsegments:
1) By Corticosteroids: Triamcinolone Acetonide, Methylprednisolone Acetate, Dexamethasone Sodium Phosphate, Betamethasone
2) By Local Anesthetics: Lidocaine, Bupivacaine, Ropivacaine, Prilocaine
3) By Hyaluronic Acid: High Molecular Weight Hyaluronic Acid, Low Molecular Weight Hyaluronic Acid, Cross-Linked Hyaluronic Acid, Non-Cross-Linked Hyaluronic Acid
4) By Other Product Types: Platelet-Rich Plasma, Biological Agents, Combination Formulations
Facet-Joint Injection Market Industry Trends: What’s Reshaping Demand?
Leading companies in the facet-joint injection market are concentrating on developing novel products, such as facet fusion systems, aimed at providing more prolonged relief and better treatment results. Facet fusion systems are medical devices specifically engineered to stabilize and fuse the spinal facet joints by encouraging bone growth connecting neighboring vertebrae. As an illustration, in March 2025, Aurora Spine Corporation, a medical device company situated in the US, revealed that the AEROTM Facet Fusion System, which is its latest product, obtained 510(k) clearance from the U.S. Food and Drug Administration (FDA). The system features an integrated titanium plasma spray coating designed to enhance osseointegration and its capacity for fusion. It supports a range of implant sizes to suit diverse patient anatomies and provides radiolucent instrumentation to improve visibility during surgical procedures. These attributes collectively strive to elevate procedural efficiency and the long-term effectiveness in addressing chronic back pain originating from facet joint disorders.
Facet-Joint Injection Market Key Players Shaping Industry Direction
Major companies operating in the facet-joint injection market are Abbott Laboratories, B. Braun Melsungen AG, BD (Becton Dickinson and Company), Cook Medical, Teleflex Incorporated, Merit Medical Systems Inc., Halyard Health, ICU Medical Inc., Pajunk GmbH Medizintechnologie, Avanos Medical Inc., Vygon SA, Cardinal Health Inc., Terumo Corporation, Nipro Corporation, Septodont Holding, Fresenius Kabi AG, Hikma Pharmaceuticals PLC, Sun Pharmaceutical Industries Ltd., Aurobindo Pharma Ltd., Zydus Lifesciences Ltd., Amneal Pharmaceuticals LLC, Lupin Limited, Piramal Pharma Limited, Intas Pharmaceuticals Ltd., Gland Pharma Limited, Amphastar Pharmaceuticals Inc., Fresenius Medical Care, Baxter International Inc., McKesson Corporation
View The Full Facet-Joint Injection Market Report:
Facet-Joint Injection Market Geographic Landscape: Which Region Leads Industry Growth?
North America was the largest region in the facet-joint injection market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the facet-joint injection market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Reach Out To Our Team:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas: +1 310-496-7795
Asia: +44 7882 955267 & +91 8897263534
Europe: +44 7882 955267
Email us at: marketing@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
